{"id":788492,"date":"2023-10-05T14:37:06","date_gmt":"2023-10-05T18:37:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/"},"modified":"2023-10-05T14:37:06","modified_gmt":"2023-10-05T18:37:06","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/","title":{"rendered":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)"},"content":{"rendered":"
\n

BALA CYNWYD, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n

\n SP\u00ae Plus Corporation (Nasdaq – SP)<\/strong>\n <\/p>\n

Under the terms of the Merger Agreement, SP+ will be acquired by Metropolis Technologies, Inc. (\u201cMetropolis\u201d) for $54.00 per share in cash for each share of SP+ held. The deal has an aggregate enterprise value of approximately $1.5 billion. The investigation concerns whether the SP+ Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Metropolis is paying fair value to shareholders of the Company.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/sp-plus-corporation-nasdaq-sp\/<\/a>.<\/p>\n

\n Orchard Therapeutics plc (Nasdaq – ORTX)<\/strong>\n <\/p>\n

Under the terms of the agreement, Orchard will be acquired by Kyowa Kirin Co., Ltd. (\u201cKyowa Kirin\u201d) for $16.00 per American Depositary Share (ADS) in cash (approximately $387.4 million), under which Orchard shareholders will hold an additional contingent value right (\u201cCVR\u201d) of $1.00 per ADS. The investigation concerns whether the Orchard Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Kyowa Kirin is paying fair value to shareholders of the Company.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/orchard-therapeutics-plc-nasdaq-ortx\/<\/a>.<\/p>\n

\n Summit Materials (NYSE – SUM)<\/strong>\n <\/p>\n

Under the terms of the agreement, Summit will merge with Argos North America Corp. (\u201cArgos\u201d). The companies will combine in a cash and stock transaction valued at $3.2 billion. Post close, Argos will have a 31% interest in Summit. The investigation concerns whether the Summit Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of Summit shareholders in the combined company.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/summit-materials-nyse-sum\/<\/a>.<\/p>\n

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BALA CYNWYD, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. SP\u00ae Plus Corporation (Nasdaq – SP) Under the terms of the Merger Agreement, SP+ will be acquired by Metropolis Technologies, Inc. (\u201cMetropolis\u201d) for $54.00 per share in cash for each share of SP+ held. The deal has an aggregate enterprise value of approximately $1.5 billion. The investigation concerns whether the SP+ Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Metropolis is paying fair value to … <\/p>\n

Continue reading “BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-788492","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. SP\u00ae Plus Corporation (Nasdaq – SP) Under the terms of the Merger Agreement, SP+ will be acquired by Metropolis Technologies, Inc. (\u201cMetropolis\u201d) for $54.00 per share in cash for each share of SP+ held. The deal has an aggregate enterprise value of approximately $1.5 billion. The investigation concerns whether the SP+ Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Metropolis is paying fair value to … Continue reading "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-05T18:37:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)\",\"datePublished\":\"2023-10-05T18:37:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/\"},\"wordCount\":409,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/\",\"name\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=\",\"datePublished\":\"2023-10-05T18:37:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. SP\u00ae Plus Corporation (Nasdaq – SP) Under the terms of the Merger Agreement, SP+ will be acquired by Metropolis Technologies, Inc. (\u201cMetropolis\u201d) for $54.00 per share in cash for each share of SP+ held. The deal has an aggregate enterprise value of approximately $1.5 billion. The investigation concerns whether the SP+ Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Metropolis is paying fair value to … Continue reading \"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-05T18:37:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)","datePublished":"2023-10-05T18:37:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/"},"wordCount":409,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/","name":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq - SP), Orchard Therapeutics plc (Nasdaq - ORTX), Summit Materials (NYSE - SUM) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=","datePublished":"2023-10-05T18:37:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NDUxNSM1ODU5NTA1IzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-sp-plus-corporation-nasdaq-sp-orchard-therapeutics-plc-nasdaq-ortx-summit-materials-nyse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SP\u00ae Plus Corporation (Nasdaq – SP), Orchard Therapeutics plc (Nasdaq – ORTX), Summit Materials (NYSE – SUM)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/788492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=788492"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/788492\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=788492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=788492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=788492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}